Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance

J Inflamm (Lond). 2023 Mar 20;20(1):11. doi: 10.1186/s12950-023-00333-2.

Abstract

The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection can be asymptomatic or cause a disease (COVID-19) characterized by different levels of severity. The main cause of severe COVID-19 and death is represented by acute (or acute on chronic) respiratory failure and acute respiratory distress syndrome (ARDS), often requiring hospital admission and ventilator support.The molecular pathogenesis of COVID-19-related ARDS (by now termed c-ARDS) is still poorly understood. In this review we will discuss the genetic susceptibility to COVID-19, the pathogenesis and the local and systemic biomarkers correlated with c-ARDS and the therapeutic options that target the cell signalling pathways of c-ARDS.

Keywords: ARDS; Biomarkers; COVID-19; Chemokines; Cytokines; SARS-CoV-2.

Publication types

  • Review